D
BioNTech SE BNTX
$99.47 $2.012.06%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Revenue -52.12% -69.09% -76.63% -77.64% -66.14%
Total Other Revenue -- -- -- -- --
Total Revenue -52.12% -69.09% -76.63% -77.64% -66.14%
Cost of Revenue -19.55% -59.44% -67.24% -79.80% -82.56%
Gross Profit -55.47% -70.54% -78.25% -77.18% -62.51%
SG&A Expenses 9.49% 12.07% 2.47% 3.25% -2.15%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses 352.68% 2,222.57% -96.98% -113.06% -135.71%
Total Operating Expenses 50.78% 11.03% -22.51% -45.54% -56.32%
Operating Income -122.43% -114.77% -104.59% -92.13% -70.66%
Income Before Tax -108.92% -104.42% -98.29% -90.79% -76.19%
Income Tax Expenses -83.24% -82.16% -98.63% -92.72% -79.04%
Earnings from Continuing Operations -117.67% -112.20% -98.16% -90.07% -75.03%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -117.67% -112.20% -98.16% -90.07% -75.03%
EBIT -122.43% -114.77% -104.59% -92.13% -70.66%
EBITDA -117.48% -111.59% -102.66% -91.03% -69.97%
EPS Basic -117.83% -112.22% -98.11% -89.98% -74.95%
Normalized Basic EPS -105.67% -102.99% -97.51% -90.35% -75.75%
EPS Diluted -118.28% -112.77% -98.13% -89.58% -73.70%
Normalized Diluted EPS -105.93% -103.22% -97.51% -89.97% -74.57%
Average Basic Shares Outstanding -0.41% -0.66% -0.88% -0.85% -0.67%
Average Diluted Shares Outstanding -0.91% -2.28% -3.99% -4.94% -5.73%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings